Nori Appointed to Cornell Department of Radiation Oncology

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 3
Volume 5
Issue 3

FLUSHING, NY--The New York Hospital-Cornell Medical Center has appointed Dattatreyudu Nori, MD, a pioneer in the subspecialty of brachytherapy, to the position of professor and chairman of the Department of Radiation Oncology.

FLUSHING, NY--The New York Hospital-Cornell Medical Center hasappointed Dattatreyudu Nori, MD, a pioneer in the subspecialtyof brachytherapy, to the position of professor and chairman ofthe Department of Radiation Oncology.

Dr. Nori will remain as professor and chairman of the Departmentof Radiation Oncology and director of Oncology at The New YorkHospital Medical Center of Queens, which is affiliated with theNew York Hospital-Cornell Medical Center and is a member of theNew York Hospital Care Network.

In his new position, Dr. Nori will direct the department's clinicalactivities, its research program, and the training of residentphysicians in radiation oncology.

He will also oversee the administration of the radiation oncologyprograms for the New York Hospital Care Network's 13 member hospitals.The combined network program will be one of the largest in thecountry, providing state-of-the-art radiation treatments to morethan 3,000 new patients each year.

Recent Videos
Kelley A. Rone, DNP, RN, AGNP-c, highlights the importance of having end-of-life discussions early in a patient’s cancer treatment course.
Patients treated with BCMA-directed immunotherapies for myeloma may experience susceptibility to severe infections following treatment.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series
BCMA testing tracks clinical changes faster without the need for marker expression vs monoclonal immunoglobulin, a conventional multiple myeloma marker.
Related Content